MedRx Co., Ltd (TYO:4586)

MedRx Statistics

Total Valuation

MedRx has a market cap or net worth of JPY 3.86 billion. The enterprise value is 2.40 billion.

Market Cap	3.86B
Enterprise Value	2.40B

Important Dates

The next estimated earnings date is Friday, August 14, 2026.

Earnings Date	Aug 14, 2026
Ex-Dividend Date	n/a

Share Statistics

MedRx has 59.37 million shares outstanding. The number of shares has increased by 24.01% in one year.

Current Share Class	59.37M
Shares Outstanding	59.37M
Shares Change (YoY)	+24.01%
Shares Change (QoQ)	-0.10%
Owned by Insiders (%)	5.74%
Owned by Institutions (%)	9.29%
Float	54.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	29.46
PB Ratio	2.11
P/TBV Ratio	2.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.21
EV / Sales	18.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 12.96

Current Ratio	12.96
Quick Ratio	11.74
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -41.92% and return on invested capital (ROIC) is -27.01%.

Return on Equity (ROE)	-41.92%
Return on Assets (ROA)	-25.11%
Return on Invested Capital (ROIC)	-27.01%
Return on Capital Employed (ROCE)	-41.04%
Weighted Average Cost of Capital (WACC)	7.18%
Revenue Per Employee	6.24M
Profits Per Employee	-35.52M
Employee Count	21
Asset Turnover	0.07
Inventory Turnover	0.07

Taxes

In the past 12 months, MedRx has paid 9.00 million in taxes.

Income Tax	9.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.33% in the last 52 weeks. The beta is 0.53, so MedRx's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	+8.33%
50-Day Moving Average	86.44
200-Day Moving Average	108.57
Relative Strength Index (RSI)	25.38
Average Volume (20 Days)	541,245

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedRx had revenue of JPY 131.00 million and -746.00 million in losses. Loss per share was -13.16.

Revenue	131.00M
Gross Profit	130.00M
Operating Income	-769.00M
Pretax Income	-737.00M
Net Income	-746.00M
EBITDA	-762.25M
EBIT	-769.00M
Loss Per Share	-13.16

Balance Sheet

The company has 1.46 billion in cash and n/a in debt, with a net cash position of 1.46 billion or 24.64 per share.

Cash & Cash Equivalents	1.46B
Total Debt	n/a
Net Cash	1.46B
Net Cash Per Share	24.64
Equity (Book Value)	1.83B
Book Value Per Share	30.84
Working Capital	1.51B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	6.75M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	99.24%
Operating Margin	-587.02%
Pretax Margin	-562.60%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MedRx does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.01%
Shareholder Yield	-24.01%
Earnings Yield	-19.33%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MedRx has an Altman Z-Score of 18.23.

Altman Z-Score	18.23
Piotroski F-Score	n/a